Results 31 to 40 of about 1,532,958 (269)
Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia
Journal of Clinical Medicine, 2020 Septicaemia likely results in high case-fatality rates in the present multidrug-resistant (MDR) era. Amongst them are hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), two frequent fatal septicaemic entities amongst ...
S. Jean +5 more
semanticscholar +1 more source
Community-acquired bacterial pneumonia in adults: An update
The Indian journal of medical research, 2020 Community-acquired pneumonia (CAP) is the prominent cause of mortality and morbidity with important clinical impact across the globe. India accounts for 23 per cent of global pneumonia burden with case fatality rates between 14 and 30 per cent, and ...
V. Eshwara, C. Mukhopadhyay, J. Rello
semanticscholar +1 more source
Usefulness of cellular analysis of bronchoalveolar lavage fluid for predicting the etiology of pneumonia in critically ill patients. [PDF]
PLoS ONE, 2014 The usefulness of bronchoalveolar lavage (BAL) fluid cellular analysis in pneumonia has not been adequately evaluated. This study investigated the ability of cellular analysis of BAL fluid to differentially diagnose bacterial pneumonia from viral ...
Sang-Ho Choi +12 more
doaj +1 more source
Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review
Italian Journal of Pediatrics, 2020 Background and objectives The goal of this literature review is to compare current studies regarding the accuracy of different serum markers in differentiating viral from bacterial pneumonia in the pediatric population with what is employed in the ...
Jithin Thomas +4 more
semanticscholar +1 more source
Procalcitonin and C-reactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malaria-endemic area. [PDF]
PLoS ONE, 2010 Pneumonia is the major cause of mortality and morbidity in children worldwide. Procalcitonin (PCT) and C-reactive protein (CRP) are used in developed countries to differentiate between viral and bacterial causes of pneumonia.
Núria Díez-Padrisa +9 more
doaj +1 more source
Longitudinal characteristics of cytokine profiles in the peripheral blood of COVID-19 and bacterial pneumonia patients [PDF]
Xin yixue, 2022 Objective To investigate the differences of cytokine profiles between patients with novel COVID-19 and bacterial pneumonia, unravel the immunopathological mechanism of COVID-19, and provide evidence for new therapeutic targets in COVID-19.
Luo Siwei, Yao Yachao, Zhong Limei, Hu Liangshan, Xiao Wei, Fang Xiaolin, Cao Donglin
doaj +1 more source
Cleveland Clinic journal of medicine, 2020 In COVID-19, respiratory infection with SARS-CoV-2 plus another virus (viral co-infection) or with SARS-CoV-2 plus a bacterial pathogen (combined viral and bacterial pneumonia) has been described.
Chao-ping Wu, Fatima Adhi, K. Highland
semanticscholar +1 more source
Journal of Public Health in Africa, 2022 Introduction. Before the introduction of vaccination to protect children from pneumonia, Streptococcus pneumoniae and Haemophilus influenzae type B (HiB) were the most frequent aetiological agents causing bacterial pneumonia in children under five years ...
Chukwuemeka Onwuchekwa +6 more
doaj +1 more source
Journal of Global Health, 2020 Background We are communicating the results of investigating statistics on SARS-CoV-2-related pneumonias in Russia: percentage, mortality, cases with other viral agents, cases accompanied by secondary bacterial pneumonias, age breakdown, clinical course ...
K. Sharov
semanticscholar +1 more source
COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia
Infectious Disease and Therapy, 2020 This manuscript aims to highlight the risk of Ventilator-Associated Bacterial Pneumonia (VAP) in COVID-19 inpatients. The co-infection has the potential to worsen clinical condition and increase mortality in these patients, as well as to prolong and ...
H. Póvoa +2 more
semanticscholar +1 more source